Liu Y, Liu Z J, Shen Q, Wu J Y, Fan Y, Li D R, Yu W, He Z S
Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center, Beijing 100034, China.
Department of Radiology, Peking University First Hospital, Beijing 100034, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Aug 18;52(4):621-624. doi: 10.19723/j.issn.1671-167X.2020.04.004.
To investigate the clinical and pathologic characteristics, diagnosis, treatment, prognosis and survival of prostatic stromal tumor of uncertain malignant potential.
Overall 14 patients with prostatic stromal tumor of uncertain malignant potential were treated from October 2008 to April 2020, the patient age ranged from 27 to 78 years (mean 54 years). The disease duration was 1 to 180 months (mean duration of 46 months). The clinical manifestations mainly included urinary obstructive symptoms and urethral irritating symptoms. The tumors were located in the peripheral zone or the transition zone. Digital rectum examination indicated prostatic tumor. Serum prostatic specific antigen level was always normal or elevated. Transrectal ultrasonography and magnetic resonance imaging indicated prostatic tumor. Magnetic resonance imaging in showed large, round, well-defined masses, which were diffusely heterogeneous signal on T2 weighted imaging. Following the administration of intravenous contrast medium, the lesion had diffuse and heterogeneous enhancement.
In the study, 3 cases underwent prostate biopsy, 2 cases underwent transurethral resection of the prostate, 9 cases underwent radical excision or transurethral resection of the prostate with definite diagnosis of pathologic features. Under the light microscope, the interstitial cells of stromal tumor of uncertain malignant potential were overgrowth and fusiform cells showed some degree of pleomorphism, nuclei with few mitotic figures, and necrosis was not often seen. Immunohistochemical staining showed that prostate specific antigen was negative, while vimentin was positive in the tumor tissue, CD34, progesterone receptor and smooth muscle actin were positive in the majority, and Ki67 positive index was 1%-20% (mean 6%). Twelve cases were followed-up, and the time of survival varied from 10 to 96 months (mean 65 months), two cases were lost to the follow-up, one case died of disease at the end of 10 months, nine cases were free of disease recurrence after surgery, two cases underwent more transurethral resection of the prostate due to local recurrence.
STUMP is a very rare tumor of the specialized prostatic stroma with an unpredictable clinical behavior. The clinical manifestations, transrectal ultrasonography and magnetic resonance imaging are valuable for the diagnosis of prostatic stromal tumor of uncertain malignant potential. Its definite diagnosis depends on pathological examination. Up to now, early surgery and combined therapy are effective treatments for prostatic stromal tumor of uncertain malignant potential.
探讨具有不确定恶性潜能的前列腺间质瘤的临床及病理特征、诊断、治疗、预后及生存情况。
2008年10月至2020年4月共治疗14例具有不确定恶性潜能的前列腺间质瘤患者,患者年龄27至78岁(平均54岁)。病程1至180个月(平均46个月)。临床表现主要为尿路梗阻症状及尿道刺激症状。肿瘤位于外周带或移行带。直肠指检提示前列腺肿瘤。血清前列腺特异性抗原水平多正常或升高。经直肠超声及磁共振成像提示前列腺肿瘤。磁共振成像显示肿块大、圆形、边界清晰,T2加权像呈弥漫性信号不均质。静脉注射造影剂后,病变呈弥漫性不均匀强化。
本研究中,3例行前列腺穿刺活检,2例行经尿道前列腺切除术,9例行根治性切除或经尿道前列腺切除术并明确病理特征。光镜下,具有不确定恶性潜能的间质瘤间质细胞过度增生,梭形细胞有一定程度的异型性,核分裂象少见,坏死不常见。免疫组化染色显示肿瘤组织中前列腺特异性抗原阴性,波形蛋白阳性,多数病例CD34、孕激素受体及平滑肌肌动蛋白阳性,Ki67阳性指数为1% - 20%(平均6%)。12例进行随访,生存时间10至96个月(平均65个月),2例失访,1例在10个月时死于疾病,9例术后无疾病复发,2例因局部复发再次行经尿道前列腺切除术。
具有不确定恶性潜能的前列腺间质瘤是一种非常罕见的前列腺特殊间质肿瘤,临床行为难以预测。临床表现、经直肠超声及磁共振成像对具有不确定恶性潜能的前列腺间质瘤的诊断有重要价值。其确诊依赖于病理检查。目前,早期手术及综合治疗是治疗具有不确定恶性潜能的前列腺间质瘤的有效方法。